NADPH oxidase 1 promotes hepatic steatosis in obese mice and is abrogated by augmented skeletal muscle mass
American Journal of Physiology-Gastrointestinal and Liver Physiology · 2024
DOI: 10.1152/ajpgi.00153.2023 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, 2024. Verfasst von Sebastian Larion und 9 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, Georgia, United States. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NHLBI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
This study documents a novel mechanism by which changes in body composition, notably increased muscle mass, protect against fatty liver disease. This mechanism involves NADPH oxidase 1 (NOX1), an enzyme that increases superoxide and increases insulin signaling, leading to increased fat accumulation in the liver. NOX1 may represent a new early target for preventing fatty liver to stave off later liver diseases such as cirrhosis or liver cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, Georgia, United States.
- Department of Medicine, Medical College of Georgia, Augusta University, Augusta, Georgia, United States.
- Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
- Division of Gastroenterology, Geisinger Health System, Danville, Pennsylvania, United States.
- Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, Georgia, United States.
- Department of Physiology, Medical College of Georgia, Augusta University, Augusta, Georgia, United States.
ORCID-Profile: Caleb A Padgett, Jennifer A Thompson, Joshua T Butcher, Eric J Belin de Chantemèle, David J Fulton, David W Stepp
Förderung
- NICHD NIH HHS
- NHLBI NIH HHS
- NIDDK NIH HHS
- NIA NIH HHS
- HHS | National Institutes of Health
- HHS
Zitieren
APA
Larion, S., Padgett, C. A., Mintz, J. D., Thompson, J. A., Butcher, J. T., Belin de Chantemèle, E. J., Haigh, S., Khurana, S., Fulton, D. J., & Stepp, D. W. (2024). NADPH oxidase 1 promotes hepatic steatosis in obese mice and is abrogated by augmented skeletal muscle mass. American Journal of Physiology-Gastrointestinal and Liver Physiology. https://doi.org/10.1152/ajpgi.00153.2023
Vancouver
Larion S, Padgett CA, Mintz JD, Thompson JA, Butcher JT, Belin de Chantemèle EJ, et al. NADPH oxidase 1 promotes hepatic steatosis in obese mice and is abrogated by augmented skeletal muscle mass. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2024. doi:10.1152/ajpgi.00153.2023
BibTeX
@article{Larion2024,
author = {Larion, Sebastian and Padgett, Caleb A and Mintz, James D and Thompson, Jennifer A and Butcher, Joshua T and Belin de Chantemèle, Eric J and Haigh, Stephen and Khurana, Sandeep and Fulton, David J and Stepp, David W},
title = {NADPH oxidase 1 promotes hepatic steatosis in obese mice and is abrogated by augmented skeletal muscle mass},
journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
year = {2024},
doi = {10.1152/ajpgi.00153.2023}
}
EUVIMED